Detalhe da pesquisa
1.
Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.
South Asian J Cancer
; 13(1): 66-76, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721097